Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway.

Soulier J, Leblanc T, Larghero J, Dastot H, Shimamura A, Guardiola P, Esperou H, Ferry C, Jubert C, Feugeas JP, Henri A, Toubert A, SociƩ G, Baruchel A, Sigaux F, D'Andrea AD, Gluckman E.

Blood. 2005 Feb 1;105(3):1329-36. Epub 2004 Sep 21.

2.

Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.

Siddique MA, Nakanishi K, Taniguchi T, Grompe M, D'Andrea AD.

Exp Hematol. 2001 Dec;29(12):1448-55.

PMID:
11750104
3.

Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.

Yamashita T, Nakahata T.

Int J Hematol. 2001 Jul;74(1):33-41. Review.

PMID:
11530803
4.

Regulation of the Fanconi anemia pathway by monoubiquitination.

Gregory RC, Taniguchi T, D'Andrea AD.

Semin Cancer Biol. 2003 Feb;13(1):77-82. Review.

PMID:
12507559
5.

The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.

Taniguchi T, D'Andrea AD.

Blood. 2002 Oct 1;100(7):2457-62.

6.

FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.

Gordon SM, Alon N, Buchwald M.

J Biol Chem. 2005 Oct 28;280(43):36118-25. Epub 2005 Aug 26.

7.

Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.

Gallmeier E, Hucl T, Calhoun ES, Cunningham SC, Bunz F, Brody JR, Kern SE.

Cancer Biol Ther. 2007 May;6(5):654-60. Epub 2007 Feb 7.

PMID:
17387268
8.

X-linked inheritance of Fanconi anemia complementation group B.

Meetei AR, Levitus M, Xue Y, Medhurst AL, Zwaan M, Ling C, Rooimans MA, Bier P, Hoatlin M, Pals G, de Winter JP, Wang W, Joenje H.

Nat Genet. 2004 Nov;36(11):1219-24. Epub 2004 Oct 24.

PMID:
15502827
9.

Breast cancer and Fanconi anemia: what are the connections?

Zdzienicka MZ, Arwert F.

Trends Mol Med. 2002 Oct;8(10):458-60.

PMID:
12383764
10.

Impaired removal of DNA interstrand cross-link in Nijmegen breakage syndrome and Fanconi anemia, but not in BRCA-defective group.

Tsuchida K, Komatsu K.

Cancer Sci. 2008 Nov;99(11):2238-43. doi: 10.1111/j.1349-7006.2008.00915.x. Epub 2008 Sep 1.

11.

The Fanconi anaemia/BRCA pathway.

D'Andrea AD, Grompe M.

Nat Rev Cancer. 2003 Jan;3(1):23-34. Review.

PMID:
12509764
12.

Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.

Houghtaling S, Granville L, Akkari Y, Torimaru Y, Olson S, Finegold M, Grompe M.

Cancer Res. 2005 Jan 1;65(1):85-91.

13.

Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.

Lyakhovich A, Surralles J.

Cancer Lett. 2006 Jan 28;232(1):99-106. Epub 2005 Oct 21. Review.

PMID:
16246487
14.

"Dub"bing a tumor suppressor pathway.

Niedzwiedz W, Patel KJ.

Cancer Cell. 2005 Feb;7(2):114-5. Review.

15.

The interplay of Fanconi anemia proteins in the DNA damage response.

Wang X, D'Andrea AD.

DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1063-9. Review.

PMID:
15279794
16.

The molecular biology of Fanconi anemia.

Tamary H, Bar-Yam R, Zemach M, Dgany O, Shalmon L, Yaniv I.

Isr Med Assoc J. 2002 Oct;4(10):819-23.

17.

Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

Levitus M, Rooimans MA, Steltenpool J, Cool NF, Oostra AB, Mathew CG, Hoatlin ME, Waisfisz Q, Arwert F, de Winter JP, Joenje H.

Blood. 2004 Apr 1;103(7):2498-503. Epub 2003 Nov 20.

18.

The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.

Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, Rio P, Batish SD, Kalb R, Velleuer E, Barral S, Ott J, Petrini J, Schindler D, Hanenberg H, Auerbach AD.

Nat Genet. 2005 Sep;37(9):931-3. Epub 2005 Aug 21.

PMID:
16116424
19.

Chromosomal breakage study in children suspected with Fanconi anemia in the Indian population.

Korgaonkar S, Ghosh K, Jijina F, Vundinti BR.

J Pediatr Hematol Oncol. 2010 Nov;32(8):606-10. doi: 10.1097/MPH.0b013e3181e8865f.

PMID:
20881871
20.

Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.

Ferrer M, de Winter JP, Mastenbroek DC, Curiel DT, Gerritsen WR, Giaccone G, Kruyt FA.

Cancer Gene Ther. 2004 Aug;11(8):539-46.

PMID:
15192709

Supplemental Content

Support Center